Related Experiment Video
Updated: Apr 21, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
[New antibiotics prior to approval: is this the end of the innovative stagnation?]
1Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Pettenkoferstr. 8a, 80336, München, Deutschland, jbogner@med.lmu.de.
Background:
Therapeutic efficacy and safety in infections due to multiresistant bacteria can be improved by the clinical development of new compounds and devising new derivatives of already useful antibiotics. Due to a striking global increase of multiresistant gram-negative and gram-positive organisms, new antibiotics are urgently needed. This paper provides a review of new pharmaceuticals which are already in clinical development, mainly in phase III trials.
Conclusion:
Each of these new trials increases the possibility of new antibiotics receiving approval.
More Related Videos
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA

